acad conf call | ACAD Message Board Posts


ACADIA Pharmaceuticals Inc.

  ACAD website

ACAD   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  19709 of 19725  at  11/2/2023 5:57:40 PM  by

divadog2

The following message was updated on 11/2/2023 5:57:40 PM.

acad conf call

You can get the numbers from the ER. In the narative it is clear Daybue is doing
outstanding in the real world . Persistence is good, insurance is growing
with delays by insurer to see how it helps,but growing. Nuplazid stable and
gaining some market share. Pipeline progressing to P2/3 by end of year. Daydue
is the story for now and Europe is yet to gear up.


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 8  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board




Financial Market Data provided by
.
Loading...